The short version

Among nutritional options studied for canine osteoarthritis, fish-oil omega-3s have the strongest evidence. Randomized trials found improved weight bearing and daily function in dogs fed high-omega-3 diets. Veterinary pain guidelines place omega-3s among first-line tools for chronic pain. That does not mean every format or dose works equally well.

What the research actually says

• In 38 dogs with osteoarthritis, a fish-oil test food produced a 5.6% improvement in peak vertical force after 90 days, compared with 0.4% for the control food. Dogs receiving the test food were seven times as likely to improve. Roush, Dodd, Fritsch et al., 2010, Journal of the American Veterinary Medical Association.
• A 2022 review of 57 articles and 72 trials found “evident clinical analgesic efficacy” for omega-3-enriched diets and supplements—the strongest verdict among the nutraceutical groups reviewed. Barbeau-Grégoire, Otis, Cournoyer et al., 2022, International Journal of Molecular Sciences.
• The 2022 AAHA guidelines place omega-3 fatty acids in Tier 1 for chronic pain in dogs, alongside weight optimization and moderate daily activity. Gruen, Lascelles et al., 2022, Journal of the American Animal Hospital Association.

What this means for your dog

Ask your veterinarian about an EPA-and-DHA target that fits your dog’s diet, weight, medications, and health history. Compare products by their stated EPA+DHA amount rather than by a vague “fish oil” total. Treat omega-3s as one part of a plan that can also include weight management, controlled exercise, medication, and rehabilitation.

The short version

Keeping a dog lean is one of the most evidence-backed mobility choices available. A landmark lifetime Labrador study linked lifelong food restriction with longer life and later chronic disease. Follow-up work found less severe hip and shoulder osteoarthritis. Even modest weight loss can help dogs that already have osteoarthritis.

What the research actually says

• Forty-eight Labrador Retrievers were paired from puppyhood; one dog in each pair received 25% less food. The restricted group lived longer and developed signs of chronic disease later. Kealy, Lawler, Ballam et al., 2002, Journal of the American Veterinary Medical Association.
• The same lifetime cohort showed less severe shoulder osteoarthritis at ages six and eight. Runge, Biery, Lawler et al., 2008, Veterinary Surgery.
• Published thresholds summarized in a 2026 clinical paper put subjective lameness improvement around 6.1% weight loss and objective gait improvement around 8.85%. Marshall et al., 2010, Veterinary Research Communications, summarized in Journal of Veterinary Clinics, 2026.
• A systematic review confirms body weight and body condition as modifiable osteoarthritis risk factors while warning that studies often blur body size and body condition. “Body weight, gonadectomy, and other risk factors,” 2023, Frontiers in Veterinary Science.

What this means for your dog

Ask your vet to score body condition and set a safe target. Use measured meals, include treats in the daily total, and track weight on the same scale when possible. For a dog with osteoarthritis, gradual change protects muscle better than aggressive restriction.

The short version

Strict rest is usually the wrong default for a dog with osteoarthritis. Regular, low-impact, controlled exercise helps preserve strength and function. Consistency matters more than one large weekend outing. The right amount is the amount your dog can recover from without extra stiffness or limping.

What the research actually says

• An intensive, therapist-supervised rehabilitation program that included underwater treadmill work improved mobility, reduced pain, and supported weight loss in dogs with osteoarthritis. Mlacnik et al., 2006, Journal of the American Veterinary Medical Association, summarized by Veterinary Practice News.
• Moderate daily activity is a Tier 1 chronic-pain therapy in the AAHA framework. Gruen, Lascelles et al., 2022, Journal of the American Animal Hospital Association.

What this means for your dog

Favor controlled walks, steady footing, and a repeatable daily schedule. Increase time or intensity gradually. Pull back and call your vet if you see new limping, reluctance to rise, or noticeably worse stiffness later that day or the next morning.

The short version

LOAD and CBPI give owners a structured way to record mobility and pain-related behavior. LOAD covers everyday function across 13 questions. CBPI separates pain severity from how pain interferes with activity and enjoyment. Both are best used to track trends, not to label a single score as a diagnosis.

What the research actually says

• LOAD scores 13 everyday function questions from 0 to 4, for a total from 0 to 52; higher scores mean greater mobility impairment. CBPI uses four pain-severity items and six pain-interference items scored from 0 to 10.
• In 222 dogs with osteoarthritis, LOAD and CBPI showed construct validity and correlated with force-platform peak vertical force symmetry—evidence that owner reports track with objective gait measurement. Walton, Cowderoy, Lascelles & Innes, 2013, PLoS ONE.
• Independent psychometric work also found good internal consistency, moderate-to-strong test–retest reliability, and responsiveness after anti-inflammatory treatment. Published minimal clinically important differences help distinguish meaningful change from normal score noise.

What this means for your dog

Answer the same questions at regular intervals and watch the direction over time. Keep the context—medication changes, unusual activity, injury, or illness—beside the score. Bring a sustained change to your veterinarian; a check-in can sharpen the conversation, not replace the exam.

The short version

Pet supplements do not go through a dedicated pre-market approval system in the United States. The NASC Quality Seal is the main industry quality signal, backed by audits, reporting, and random testing. cGMP refers to documented manufacturing and contamination-control systems. None of that proves a product is effective.

What the research actually says

• The FDA Center for Veterinary Medicine regulates these products as animal food; there is no separate pet-supplement category like the human framework. NASC describes many joint products as operating under enforcement discretion when companies act responsibly. National Animal Supplement Council, regulatory framework overview.
• The NASC seal requires an independent audit every two years, a written quality-control manual, adverse-event reporting, labeling compliance, and random independent testing for label accuracy. National Animal Supplement Council, “NASC and the NASC Quality Seal”.
• NASC’s cGMP framework combines elements of 21 CFR Part 111 for human dietary supplements with preventive controls from 21 CFR Part 507 for animal food. In practice, that means documented procedures, qualified suppliers, batch records, and contamination controls.
• AAFCO provides model ingredient and labeling rules that states may adopt. FDA-CVM, AAFCO, and NASC play different roles; only FDA is a federal regulator.

What this means for your dog

Look for a NASC seal, individual ingredient amounts, a lot number, and real company contact information. Treat “proprietary blend” as a warning when it hides amounts. Avoid labels that say a supplement treats arthritis or cures hip dysplasia; disease-treatment claims are not appropriate for supplements.

The short version

Dogs rarely announce chronic pain the way people expect. Slower walks, hesitation before stairs, stiffness after rest, more sleep, and withdrawal from play can all matter. Behavior can reveal pain that an X-ray does not. Sudden or severe changes need prompt veterinary attention.

What the research actually says

• AAHA identifies musculoskeletal pain, including osteoarthritis, as the most common form of chronic pain in dogs. The guidelines stress owner observation because low-grade pain may look like breath-holding, lip-licking, looking away, posture change, irritability, or reduced activity—not just crying or limping. Gruen, Lascelles et al., 2022, Journal of the American Animal Hospital Association.
• Joint pain on examination and the severity seen on radiographs may correlate poorly. A dog can have dramatic X-rays with little pain, or meaningful pain with modest imaging findings.
• Osteoarthritis is not only an old-dog disease. Early stages can include mild, intermittent pain and are often missed.
• First-line care is multimodal: the guidelines include appropriate medication, omega-3s, weight optimization, moderate daily activity, and surgery when indicated.

What this means for your dog

Track changes in rising, stairs, car entry, walk pace, sleep, play, touch sensitivity, and gait. Book a veterinary exam for persistent changes, even if they seem like normal aging. Seek prompt care for sudden non-weight-bearing lameness, joint swelling or heat, crying out, refusal to rise, or any rapid change.

The short version

Green-lipped mussel has real canine research behind it. Small trials have reported less pain and swelling and better function or force-plate results. At least one lower-dose study did not improve clinical signs. The evidence is encouraging, but it does not identify one proven preparation or dose.

What the research actually says

• In an open-label dose study of 15 dogs, a green-lipped mussel oil complex improved CBPI scores, orthopedic scores, and peak vertical force after four weeks, with the clearest results in mild-to-moderate osteoarthritis. Kang, Kim, Lim & Kang, 2024, Journal of Veterinary Clinics.
• Veterinary reviews report both positive controlled findings and a lower-dose powder study that did not improve signs, suggesting the result may depend on preparation and dose. “Indications and contraindications for orally administered joint health products,” 2009, Journal of the American Veterinary Medical Association.

What this means for your dog

If you are considering green-lipped mussel, bring the exact product, form, and dose to your veterinarian rather than treating the ingredient name as enough information. Consistency between batches and transparent amounts matter when the research itself is formulation-sensitive.

The short version

Familiar does not mean proven. The strongest available synthesis found a very marked non-effect for glucosamine–chondroitin products on canine osteoarthritis pain. MSM, oral hyaluronic acid, and Boswellia lack controlled canine evidence. Curcumin is promising in people but still emerging-to-weak in dogs.

What the research actually says

Glucosamine + chondroitin

A 2022 systematic review and meta-analysis of 57 articles and 72 trials found a “very marked non-effect” for chondroitin–glucosamine products on osteoarthritis pain and said they should no longer be recommended for pain management in canine and feline osteoarthritis. Only one of nine trials showed any improvement, using a non-validated subjective measure at one time point in a poor-quality trial. Oral bioavailability cited in the review was about 12% for glucosamine hydrochloride and 5% for chondroitin sulfate in dogs. Barbeau-Grégoire, Otis, Cournoyer et al., 2022, International Journal of Molecular Sciences.

MSM

No controlled clinical trial of standalone MSM for canine osteoarthritis was identified. It is widely used and generally regarded as safe, but the dog-specific proof is not there yet; most of what is cited comes from people or horses. A 2024 orthopedic paper states that objective evidence remains lacking and efficacy is controversial. “Evaluation of an undenatured collagen type-2 nutraceutical after TPLO,” 2024, Animals.

Oral hyaluronic acid

Injected hyaluronic acid has evidence in dogs and is a veterinary procedure. That evidence says nothing about oral hyaluronic acid in a chew. No objective canine data establishing an effect of the oral form on joint function or pain were identified. “Evaluation of an undenatured collagen type-2 nutraceutical after TPLO,” 2024, Animals.

Boswellia

The canine record is essentially one small uncontrolled study of 24 dogs, in which 71% improved on lameness scores by week two, plus human and traditional use. Without a placebo group, dose confirmation, or replication, efficacy remains unknown. Clinical evidence summarized in a 2009 Journal of the American Veterinary Medical Association review.

Curcumin

Dog-specific evidence is mixed and mostly comes from combination products. A green-lipped mussel, curcumin, and blackcurrant supplement showed no significant force-plate difference from placebo. Corbee et al., 2022, Veterinary Medicine and Science. The fair summary is: promising in people, still being proven in dogs.

What this means for your dog

Do not judge a formula by the number of familiar ingredients on the front. Ask which ingredient, dose, format, and dog-specific outcome the evidence supports. A combination product may work without proving that every ingredient inside it contributed.